Patient and physician reported toxicity with two-fraction definitive high-dose-rate prostate brachytherapy: the impact of implant interval

by Alexander Harris, Mark Korpics, Zohaib Sherwani, Ahmer Farooq, Kristin Baldea, Robert Flanigan, Matthew Harkenrider, Abhishek Solanki
Published 2020-06-01

Cost in perspective: direct assessment of American market acceptability of Co-60 in gynecologic high-dose-rate brachytherapy and contrast with experience abroad

by Raymond B. Mailhot Vega, David Barbee, Wesley Talcott, Tamara Duckworth, Bhartesh A. Shah, Omar F. Ishaq, Christina Small, Anamaria R. Yeung, Carmen A. Perez, Peter B. Schiff, Ophira Ginsburg, William Small Jr, May Abdel-Wahab, Gustavo Sarria Bardales, Matthew Harkenrider
Published 2018-11-01